Associate Director - Mass Spectrometry

IND - 2028 Takeda Innovations India Private Limited; Bengaluru; Hybrid; INR 5,000,000 - 8,000,000; Full time

Benefits offered by this job

Competitive Salary + Annual Bonus

Hybrid work environment

Healthcare Insurance for family

Group Life & Accident Insurance

Health & Wellness programs & Annual健康

Job summary

Takeda Innovations India Pvt Ltd in Bengaluru is seeking a Scientific Leader with deep bioanalytical and biomarker expertise to shape strategy, build capabilities, and ensure timely delivery of PK, immunogenicity, and biomarker data for clinical trials.

The role requires expert oversight of vendors, cross‑functional collaboration, and regulatory alignment across India, EU, and global programs. Hybrid work model and global project exposure are provided.

Qualifications

• PhD in a relevant scientific discipline with 10+ years of experience, or MS with 16+ years, or BS with 18+ years (including 7+ years of industry experience).
• In-depth expertise in bioanalytical chemistry, immunology, and related bioanalytical techniques.
• Current knowledge of global, EU, and India‑specific regulatory guidance for bioanalytical/biomarker method validation and testing.

Responsibilities

• Lead and coordinate bioanalytical/biomarker deliverables across programs to meet timelines and regulatory expectations.
• Provide SME oversight of bioanalytical vendors for method development, validation, and lifecycle management.
• Interpret and apply local, EU, and global regulations to ensure inspection readiness and data integrity.

Job description

Job Description Objective / Purpose:

Scientific leader with deep bioanalytical and biomarker expertise, accountable for building capabilities, shaping the strategic direction for bioanalytical and biomarker development and implementation, and ensuring timely, compliant delivery of PK, immunogenicity, and biomarker data for clinical trials across global development programs. Serves as an expert across one or more technologies with one of them being mass spectrometry (e.g., immunoassays, cell-based assays, flow cytometry, LC-MS/MS, and genomics) and partners closely within TB&B and with cross‑functional stakeholders (e.g., QPTS, Translational Medicine, Clinical Sciences, GRA) to advance clinical assets. Applies fit‑for‑purpose, context‑of‑use, and relevant local, EU, and global regulatory principles to assay and biomarker strategies that enable timely, high‑quality portfolio decisions. Accountabilities: Lead the bioanalytical strategy and contribute to biomarker strategy for multiple global clinical development programs. Independently design and execute deliverables as the bioanalytical and biomarker SME, ensuring regulated bioanalysis meets current global guidance and applicable local/EU regulatory requirements where relevant and reflects local operational considerations for a Poland‑based role (e.g., sample handling, shipment/export limitations, and data requirements). Provide scientific and technical oversight of bioanalytical vendors (global and, where applicable, India/EU‑based) for method development, optimization, validation, lifecycle management (PK, immunogenicity, biomarkers), and clinical sample testing supporting development and post‑market commitments across GI&I, NS and Oncology. Partner with Quality to ensure vendor qualification, audit readiness, and adherence to GxP and applicable local, EU, and global regulations; ensure delivery is timely, scientifically sound, and inspection‑ready. Provide SME support for data analysis and regulatory submissions, including global submissions and, where relevant, India‑EU regulatory interactions. Review PK, immunogenicity, and biomarker results; sample analysis reports; statistical analysis plans and outputs; and relevant sections of CSRs and submission documents (e.g., ISI, IND, briefing books, IB, IMPD/CCD, CTD). Draft and support responses to health authority questions related to PK, immunogenicity, and biomarkers. Serve as a India‑based regulatory and quality SME for bioanalysis/biomarkers: interpret and apply local, EU, and global regulations and guidance for method validation and sample testing; ensure documentation, data integrity, and laboratory practices are inspection‑ready; and align with study teams on compliant sample collection, storage, chain‑of‑custody, and cross‑border shipment/export considerations. Apply fit‑for‑purpose and context‑of‑use principles in biomarker development, including clinical feasibility assessments, assay validation approaches, and implementation strategies to deliver key assays and data that inform portfolio and program decisions. Lead and coordinate a TB&B matrix team of subject matter experts and study logistics partners to plan and execute bioanalytical/biomarker deliverables in accordance with study timelines; represent TB&B on cross‑functional project teams and keep TB&B leadership informed of progress, risks, and mitigation plans. Provide input to relevant clinical and regulatory documents by consolidating SME feedback (e.g., protocols, IND/NDA/BLA submissions, briefing books, IB, CSR) and support study start‑up and database lock activities (e.g., ICF and data transfer agreements, sample reconciliation, data review/QC, and data transfer). Provide strategic bioanalysis and biomarker input and scientific expertise to global project teams, including local/EU regulatory or operational considerations as needed for an India‑based role, and lead immunogenicity risk assessment and mitigation planning from early development through commercialization across modalities and therapeutic areas. Provide strategic recommendations on biomarker technologies and outputs aligned with stakeholder needs. Provide program updates to the line leadership and study teams. Proactively manage and resolve issues, escalating critical risks and decisions in a timely manner. Build a strong cross‑functional network across Takeda and enhance Takeda visibility by participating in external bioanalysis/biomarker forums, presenting at scientific meetings, and contributing to publications.

Accountabilities:

• Lead the bioanalytical strategy and contribute to biomarker strategy for multiple global clinical development programs.
• Independently design and execute deliverables as the bioanalytical and biomarker SME, ensuring regulated bioanalysis meets current global guidance and applicable local/EU regulatory requirements where relevant and reflects local operational considerations for a Poland‑based role (e.g., sample handling, shipment/export limitations, and data requirements).
• Provide scientific and technical oversight of bioanalytical vendors (global and, where applicable, India/EU‑based) for method development, optimization, validation, lifecycle management (PK, immunogenicity, biomarkers), and clinical sample testing supporting development and post‑market commitments across GI&I, NS and Oncology.
• Partner with Quality to ensure vendor qualification, audit readiness, and adherence to GxP and applicable local, EU, and global regulations; ensure delivery is timely, scientifically sound, and inspection‑ready.
• Provide SME support for data analysis and regulatory submissions, including global submissions and, where relevant, India‑EU regulatory interactions.
• Review PK, immunogenicity, and biomarker results; sample analysis reports; statistical analysis plans and outputs; and relevant sections of CSRs and submission documents (e.g., ISI, IND, briefing books, IB, IMPD/CCD, CTD).
• Draft and support responses to health authority questions related to PK, immunogenicity, and biomarkers.
• Serve as a India‑based regulatory and quality SME for bioanalysis/biomarkers: interpret and apply local, EU, and global regulations and guidance for method validation and sample testing; ensure documentation, data integrity, and laboratory practices are inspection‑ready; and align with study teams on compliant sample collection, storage, chain‑of‑custody, and cross‑border shipment/export considerations.
• Apply fit‑for‑purpose and context‑of‑use principles in biomarker development, including clinical feasibility assessments, assay validation approaches, and implementation strategies to deliver key assays and data that inform portfolio and program decisions.
• Lead and coordinate a TB&B matrix team of subject matter experts and study logistics partners to plan and execute bioanalytical/biomarker deliverables in accordance with study timelines; represent TB&B on cross‑functional project teams and keep TB&B leadership informed of progress, risks, and mitigation plans.
• Provide input to relevant clinical and regulatory documents by consolidating SME feedback (e.g., protocols, IND/NDA/BLA submissions, briefing books, IB, CSR) and support study start‑up and database lock activities (e.g., ICF and data transfer agreements, sample reconciliation, data review/QC, and data transfer).
• Provide strategic bioanalysis and biomarker input and scientific expertise to global project teams, including local/EU regulatory or operational considerations as needed for an India‑based role, and lead immunogenicity risk assessment and mitigation planning from early development through commercialization across modalities and therapeutic areas.
• Provide strategic recommendations on biomarker technologies and outputs aligned with stakeholder needs.
• Provide program updates to the line leadership and study teams.
• Proactively manage and resolve issues, escalating critical risks and decisions in a timely manner.
• Build a strong cross‑functional network across Takeda and enhance Takeda visibility by participating in external bioanalysis/biomarker forums, presenting at scientific meetings, and contributing to publications.

Education & Competencies (Technical and Behavioral):

• PhD in a relevant scientific discipline with 10+ years of experience, or MS with 16+ years, or BS with 18+ years (including 7+ years of industry experience).
• In-depth expertise in bioanalytical chemistry, immunology, and bioanalytical techniques in the context of drug development.
• Outstanding expertise in one or more biomarker technologies (e.g., immunoassays, genomics, flow cytometry, cell-based assays, LC‑MS/MS), with a current understanding of scientific advancements and evolving best practices.
• Current knowledge of global, EU, and India‑specific regulatory guidance for bioanalytical/biomarker method validation and clinical/preclinical sample testing.
• Demonstrated ability to operationalize local, EU, and global regulatory expectations into fit‑for‑purpose bioanalytical plans, including inspection readiness, data integrity, and documentation standards.
• Experience overseeing India/EU‑based laboratories/CROs, including vendor selection/qualification support, governance, deviation management, CAPA follow‑up, and partnership with Quality.
• Strong knowledge of allied fields critical to drug development (e.g., drug metabolism, pharmacology, toxicology, pharmaceutical sciences, and clinical bioanalysis).
• Excellent oral and written communication skills, including writing, reviewing, and editing scientific documents.
• Demonstrated ability to work effectively on multi‑disciplinary, cross‑functional project teams.
• Excellent collaboration and influencing skills with an enterprise mindset; able to navigate highly complex, matrixed environments to align stakeholders and deliver through strong cross‑functional partnerships.
• Fluent in English; Indian language proficiency is preferred, with demonstrated ability to operate effectively in local and global matrixed environment.

Benefits

• Competitive Salary + Performance Annual Bonus
• Flexible work environment, including hybrid working
• Comprehensive Healthcare Insurance Plans for self, spouse, and children
• Group Term Life Insurance and Group Accident Insurance programs
• Health & Wellness programs including annual health screening, weekly health sessions for employees.
• Employee Assistance Program
• 5 days of leave every year for Voluntary Service in addition to Humanitarian Leaves
• Broad Variety of learning platforms
• Diversity, Equity, and Inclusion Programs
• No Meeting Days
• Reimbursements – Home Internet & Mobile Phone
• Employee Referral Program
• Leaves – Paternity Leave (4 Weeks) , Maternity Leave (up to 26 weeks), Bereavement Leave (5 days)

About ICC in Takeda

Takeda is leading a digital revolution. We’re not just transforming our company; we’re improving the lives of millions of patients who rely on our medicines every day. As an organization, we are committed to our cloud‑driven business transformation and believe the ICCs are the catalysts of change for our global organization. Locations Bengaluru Worker Type Employee Worker Sub-Type Regular Time Type Full time Worker Type Employee Worker Sub-Type Regular Time Type Full time Worker Type Employee Worker Sub-Type Regular Time Type Full time Worker Type Employee Worker Sub-Type Regular Time Type Full time Locations IND - Bengaluru - Research and Development Worker Type Employee Worker Sub-Type Regular Time Type Full time Takeda is an industry‑leading, global pharmaceutical company with an unwavering dedication to putting patients at the center of everything we do. We live our values of Takeda‑ism – Integrity, Fairness, Honesty, and Perseverance – and are united by our mission to strive towards Better Health and a Brighter Future for people worldwide through leading innovation in medicine. Here, everyone matters and you will be a vital contributor to our inspiring, bold mission. At Takeda, you will make an impact on people’s lives – including your own. Takeda is an equal opportunity employer. For applicants of U.S and Puerto Rico positions: Click here to learn about our commitment to Equal Employment Opportunity (EEO).